Review on transarterial chemoembolization in hepatocellular carcinoma: Palliative, combined, neoadjuvant, bridging, and symptomatic indications

European Journal of Radiology

Volumn 72, Issue 3, 2009, Pages 505-516

  Vogl, Thomas J ^a   Naguib, Nagy N N ^a   Nour Eldin, Nour Eldin A ^a   Rao, Pramod ^a   Emami, Alborz Hedayati ^a   Zangos, Stefan ^a   Nabil, Mohamed ^a   Abdelkader, Ahmed ^a  

^a UNIVERSITY HOSPITAL FRANKFURT   (Germany)

Author keywords

Combined therapies; Hepatocellular carcinoma (HCC); Review; TACE

Indexed keywords

CHEMOTHERAPEUTIC AGENTS; CHEMOTHERAPEUTIC DRUGS; COMBINED THERAPY; DRUG CONCENTRATION; EMBOLIZATION; HEPATOCELLULAR CARCINOMA; HEPATOCELLULAR CARCINOMA (HCC); LASER INDUCED; LIVER RESECTIONS; LIVER TRANSPLANTATION; LOCAL TUMOR CONTROL; NEOADJUVANT THERAPY; RADIOFREQUENCY ABLATION; THERAPEUTIC TOOLS; THERMOTHERAPIES; TRANSARTERIAL CHEMOEMBOLIZATION; TUMOR CONTROL;

ETHANOL; LIVER;

TUMORS;

ALCOHOL; CISPLATIN; CISPLATIN DERIVATIVE; DOXORUBICIN; EPIRUBICIN; GELFOAM; IODINATED POPPYSEED OIL; LIPOPHILIC PLATINUM COMPLEX; MITOMYCIN; MITOXANTRONE; SM 11355; TAMOXIFEN; UNCLASSIFIED DRUG; ZINOSTATIN MALEIC ACID STYRENE COPOLYMER;

CANCER ADJUVANT THERAPY; CANCER CONTROL; CANCER RECURRENCE; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; CHEMOEMBOLIZATION; CLINICAL TRIAL; COIL EMBOLIZATION; HUMAN; LIVER CELL CARCINOMA; LIVER RESECTION; LIVER TRANSPLANTATION; LOW LEVEL LASER THERAPY; MULTIMODALITY CANCER THERAPY; PALLIATIVE THERAPY; PATIENT SELECTION; POSTOPERATIVE CARE; PREOPERATIVE CARE; PRIORITY JOURNAL; RADIOFREQUENCY ABLATION; REVIEW; THREE DIMENSIONAL IMAGING; TRANSARTERIAL CHEMOEMBOLIZATION;

CARCINOMA, HEPATOCELLULAR; EMBOLIZATION, THERAPEUTIC; HEMOSTATICS; HUMANS; LIVER NEOPLASMS; NEOADJUVANT THERAPY; PALLIATIVE CARE;

EID: 70449641610     PISSN: 0720048X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejrad.2008.08.007     Document Type: Review

References (89)

1. Khan S.A., Taylor-Robinson S.D., Toledano M.B., Beck A., Elliott P., and Thomas H.C. Changing international trends in mortality rates for liver, biliary and pancreatic tumours. J Hepatol 37 (2002) 806-813
2. Takayasu K., Arii S., Ikai I., et al. Prospective cohort study of transarterial chemoembolization for unresectable hepatocellular carcinoma in 8510 patients. Gastroenterology 131 2 (2006) 461-469
3. Molinari M., Kachura J.R., Dixon E., et al. Transarterial chemoembolisation for advanced hepatocellular carcinoma: results from a North American cancer centre. Clin Oncol (R Coll Radiol) 18 9 (2006) 684-692
4. Llovet J.M., and Bruix J. Systematic review of randomized trials for unresectable hepatocellular carcinoma: chemoembolization improves survival. Hepatology 37 (2003) 429-442
5. Bruix J., Sala M., and Llovet J.M. Chemoembolization for hepatocellular carcinoma. Gastroenterology 127 Suppl 1 (2004) S179-S188
6. Bruix J., and Sherman M. Practice Guidelines Committee, American Association for the Study of Liver Diseases. Management of hepatocellular carcinoma. Hepatology 42 5 (2005) 1208-1236
7. Bruix J., Sherman M., Llovet J.M., et al. EASL Panel of Experts on HCC. Clinical management of hepatocellular carcinoma. Conclusions of the Barcelona-2000 EASL conference. European Association for the Study of the Liver. J Hepatol 35 3 (2001) 421-430
8. Kudo M., and Okanoue T. Japan Society of Hepatology. Management of hepatocellular carcinoma in Japan: consensus-based clinical practice manual proposed by the Japan Society of Hepatology. Oncology 72 Suppl 1 (2007) 2-15
9. Kothary N., Weintraub J.L., Susman J., and Rundback J.H. Transarterial chemoembolization for primary hepatocellular carcinoma in patients at high risk. J Vasc Interv Radiol 18 12 (2007) 1517-1526
10. Miyayama S., Matsui O., Yamashiro M., et al. Ultraselective transcatheter arterial chemoembolization with a 2-F tip microcatheter for small hepatocellular carcinomas: relationship between local tumor recurrence and visualization of the portal vein with iodized oil. J Vasc Interv Radiol 18 (2007) 365-376
11. Nakai M., Sato M., Kawai N., et al. Hepatocellular carcinoma: involvement of the internal mammary artery. Radiology 219 (2001) 147-152
12. Chung J.W., Kim H.C., Yoon J.H., et al. Transcatheter arterial chemoembolization of hepatocellular carcinoma: prevalence and causative factors of extrahepatic collateral arteries in 479 patients. Korean J Radiol 7 4 (2006) 257-266
13. Lee J.H., Won J.H., Park II S., Won J.Y., Lee D.Y., and Kang B.C. Transcatheter arterial chemoembolization of hepatocellular carcinoma with hepatic arteriovenous shunt after temporary balloon occlusion of hepatic vein. J Vasc Interv Radiol 18 (2007) 377-382
14. Marelli L., Stigliano R., Triantos C., et al. Transarterial therapy for hepatocellular carcinoma: which technique is more effective? A systematic review of cohort and randomized studies. Cardiovasc Intervent Radiol 30 1 (2007) 625
15. Favoulet P., Cercueil J.P., Faure P., et al. Increased cytotoxicity and stability of Lipiodol-pirarubicin emulsion compared to classical doxorubicin-Lipiodol: potential advantage for chemoembolization of unresectable hepatocellular carcinoma. Anticancer Drugs 12 (2001) 801-806
16. Fujiyama S., Shibata J., Maeda S., et al. Phase I clinical study of a novel lipophilic platinum complex (SM11355) in patients with hepatocellular carcinoma refractory to cisplatin/lipiodol. Br J Cancer 89 (2003) 1614-1619
17. Coldwell D.M., Stokes K.R., and Yakes W.F. Embolotherapy: agents, clinical applications, and techniques. Radiographics 14 (1994) 623-643
18. Gunji T., Kawauchi N., Akahane M., Watanabe K., Kanamori H., and Ohnishi S. Long-term outcomes of transcatheter arterial chemoembolization with autologous blood clot for unresectable hepatocellular carcinoma. Int J Oncol 21 (2002) 427-432
19. Brown D.B., Pilgram T.K., Darcy M.D., et al. Hepatic arterial chemoembolization for hepatocellular carcinoma: comparison of survival rates with different embolic agents. J Vasc Interv Radiol 16 (2005) 1661-1666
20. Rand T., Loewe C., Schoder M., et al. Arterial embolization of unresectable hepatocellular carcinoma with use of microspheres, lipiodol, and cyanoacrylate. Cardiovasc Intervent Radiol 28 (2005) 313-318
21. Llovet J.M., Sala M., Castells L., et al. Randomised controlled trial of interferon treatment for advanced hepatocellular carcinoma. Hepatology 31 (2000) 54-58
22. Varela M., Real M.I., Brunet M., et al. Chemoembolization of hepatocellular carcinoma with drug eluting beads: efficacy and doxorubicin pharmacokinetics. J Hepatol 46 3 (2007) 474-481
23. O'Suilleabhain C.B., Poon R.T., Yong J.K., Ooi G.C., Tso W.K., and Fan S.T. Factors predictive of 5-year survival after transarterial chemoembolization for inoperable hepatocellular carcinoma. Br J Surg 90 (2003) 325-331
24. Hashimoto T., Nakamura H., Tomoda K., et al. Hepatocellular carcinoma patients showing long-term complete responses to chemoembolisation. Semin Oncol 24 (1997) S26-S28
25. Taniguchi K., Nakata K., Kato Y., et al. Treatment of hepatocellular carcinoma with transcatheter arterial embolization. Analysis of prognostic factors. Cancer 73 (1994) 1341-1345
26. Trevisani F., D'Intino P.E., Caraceni P., et al. Etiologic factors and clinical presentation of hepatocellular carcinoma. Differences between cirrhotic and noncirrhotic Italian patients. Cancer 75 (1995) 2220-2232
27. Trevisani F., De Notariis S., Rossi C., and Bernardi M. Randomised control trials on chemoembolisation for hepatocellular carcinoma. Is there room for new studies?. J Clin Gastroenterol 32 (2001) 383-389
28. Rossi S., Garbagnati F., Lencioni R., et al. Percutaneous radiofrequency thermal ablation of nonresectable hepatocellular carcinoma after occlusion of tumor blood supply. Radiology 217 (2000) 119-126
29. Takamura M., Murakami T., Shibata T., et al. Microwave coagulation therapy with interruption of hepatic blood in-or outflow: an experimental study. J Vasc Interv Radiol 12 (2001) 619-622
30. Staunton M., Dodd J.D., McCormick P.A., and Malone D.E. Finding evidence based answers to practical questions in radiology: which patients with inoperable hepatocellular carcinoma will survive longer after transarterial chemoembolization?. Radiology 237 (2005) 404-413
31. Kamada K., Kitamoto M., Aikata H., et al. Combination of transcatheter arterial chemoembolization using cisplatin-lipiodol suspension and percutaneous ethanol injection for treatment of advanced small hepatocellular carcinoma. Am J Surg 184 (2002) 284-290
32. Koda M., Murawaki Y., Mitsuda A., et al. Combination therapy with transcatheter arterial chemoembolization and percutaneous ethanol injection compared with percutaneous ethanol injection alone for patients with small hepatocellular carcinoma: a randomized control study. Cancer 92 (2001) 1516-1524
33. Kim S.K., Lim H.K., Kim Y.H., et al. Hepatocellular carcinoma treated with radiofrequency ablation: spectrum of imaging findings. RadioGraphics 23 (2003) 107-121
34. Yamakado K., Nakatsuka A., Ohmori S., et al. Radiofrequency ablation combined with chemoembolization in hepatocellular carcinoma: treatment response based on tumor size and morphology. J Vasc Interv Radiol 13 (2002) 1225-1232
35. Llovet J.M., Vilana R., Bru C., et al. Increased risk of tumor seeding after percutaneous radiofrequency ablation for single hepatocellular carcinoma. Hepatology 33 (2001) 1124-1129
36. Wang Y.B., Chen M.H., Yan K., Yang W., Dai Y., and Yin S.S. Quality of life after radiofrequency ablation combined with transcatheter arterial chemoembolization for hepatocellular carcinoma: comparison with transcatheter arterial chemoembolization alone. Qual Life Res 16 (2007) 389-397
37. Zangos S., Eichler K., Balzer J.O., et al. Large-sized hepatocellular carcinoma (HCC): a neoadjuvant treatment protocol with repetitive transarterial chemoembolization (TACE) before percutaneous MR-guided laser-induced thermotherapy (LITT). Eur Radiol 17 2 (2007) 553-563
38. Vogl T.J., Mack M.G., Balzer J.O., et al. Liver metastases: neoadjuvant downsizing with transarterial chemoembolization before laser-induced thermotherapy. Radiology 229 (2003) 457-464
39. Pacella C.M., Bizzarri G., Cecconi P., et al. Hepatocellular carcinoma: long-term results of combined treatment with laser thermal ablation and transcatheter arterial chemoembolization. Radiology 219 3 (2001) 669-678
40. Zhou Z.H., Liu L.M., Chen W.W., et al. Combined therapy of transcatheter arterial chemoembolization and three-dimensional conformal radiotherapy for hepatocellular carcinoma. Br J Radiol 80 951 (2007) 194-201
41. Cheng J.C., Chuang V.P., Cheng S.H., et al. Local radiotherapy with or without transcatheter arterial chemoembolization for patients with unresectable hepatocellular carcinoma. Int J Radiat Oncol Biol Phys 47 (2000) 435-442
42. Gerundi G.E., Neri D., Merenda R., et al. Role of transarterial chemoembolization before liver resection for hepatocarcinoma. Liver Transpl 6 (2000) 619-626
43. Camma C., Schepis F., Orlando A., et al. Transarterial chemoembolization for unresectable hepatocellular carcinoma: metaanalysis of randomized controlled trials. Radiology 224 (2002) 47-54
44. Zhou J.P., Zhou W.P., Fu S.Y., Shan Y.F., Yao X.P., and Wu M.C. Influence of preoperative transcatheter arterial chemoembolization on liver function in patients with resectable large hepatocellular carcinoma. Gandan Waike Zazhi 11 (2003) 256-258
45. Zhang Z., Liu Q., He J., Yang J., Yang G., and Wu M. The effect of preoperative transcatheter hepatic arterial chemoembolization on disease-free survival after hepatectomy for hepatocellular carcinoma. Cancer 89 12 (2000) 2606-2612 15
46. Choi G.H., Kim D.H., Kang C.M., et al. Is preoperative transarterial chemoembolization needed for a resectable hepatocellular carcinoma?. World J Surg 31 12 (2007) 2370-2377
47. Xi T., Yan Z.L., Wang K., et al. Role of postoperative transcatheter arterial chemoembolization in hepatocellular carcinoma with different pathological characteristics. Zhonghua Wai Ke Za Zhi 45 9 (2007) 587-590
48. Fan J., Zhou J., Wu Z.Q., et al. Efficacy of different treatment strategies for hepatocellular carcinoma with portal vein tumor thrombosis. World J Gastroenterol 11 (2005) 1215-1219
49. Li Q., Wang J., Sun Y., et al. Efficacy of postoperative transarterial chemoembolization and portal vein chemotherapy for patients with hepatocellular carcinoma complicated by portal vein tumor thrombosis-a randomized study. World J Surg 30 (2006) 2004-2011
50. Lesurtel M., Müllhaupt B., Pestalozzi B.C., Pfammatter T., and Clavien P.A. Transarterial chemoembolization as a bridge to liver transplantation for hepatocellular carcinoma: an evidence-based analysis. Am J Transplant 6 11 (2006) 2644-2650
51. Pérez Saborido B., Meneu J.C., Moreno E., García I., Moreno A., and Fundora Y. Is transarterial chemoembolization necessary before liver transplantation for hepatocellular carcinoma?. Am J Surg 190 3 (2005) 383-387
52. Decaens T., Roudot-Thoraval F., Bresson-Hadni S., et al. Impact of pretransplantation transarterial chemoembolization on survival and recurrence after liver transplantation for hepatocellular carcinoma. Liver Transpl 11 7 (2005) 767-775
53. Stockland A.H., Walser E.M., Paz-Fumagalli R., McKinney J.M., and May G.R. Preoperative chemoembolization in patients with hepatocellular carcinoma undergoing liver transplantation: influence of emergent versus elective procedures on patient survival and tumor recurrence rate. Cardiovasc Intervent Radiol 30 5 (2007) 888-893
54. Graziadei I.W., Sandmueller H., Waldenberger P., et al. Chemoembolization followed by liver transplantation for hepatocellular carcinoma impedes tumor progression while on the waiting list and leads to excellent outcome. Liver Transpl 9 6 (2003) 557-563
55. Otto G., Herber S., Heise M., et al. Response to transarterial chemoembolization as a biological selection criterion for liver transplantation in hepatocellular carcinoma. Liver Transpl 12 8 (2006) 1260-1267
56. Battula N., Srinivasan P., Madanur M., et al. Ruptured hepatocellular carcinoma following chemoembolization: a western experience. Hepatobiliary Pancreat Dis Int 6 (2007) 49-51
57. Liu C.L., Fan S.T., Lo C.M., et al. Management of spontaneous rupture of hepatocellular carcinoma: single-center experience. J Clin Oncol 19 (2001) 3725-3732
58. Soulen M.C. Image-guided therapy of hepatic malignancies. Appl Radiol 29 (2000) 21-22
59. Leung D.A., Goin J.E., Sickles C., et al. Determinants of postembolization syndrome after hepatic chemoembolization. J Vasc Interv Radiol 12 (2001) 321-326
60. Patel N.H., Hahn D., Rapp S., Bergan K., and Coldwell D.M. Hepatic artery embolization: factors predisposing to postembolization pain and nausea. J Vasc Interv Radiol 11 (2000) 453-460
61. Chan A.O., Yuen M.F., Hui C.K., et al. A prospective study regarding the complications of transcatheter intraarterial lipiodol chemoembolization in patients with hepatocellular Carcinoma. Cancer 94 6 (2002) 1747-1752
62. Matsumoto K., Nojiri J., Takase Y., et al. Cerebral lipiodol embolism: a complication of transcatheter arterial chemoembolization for hepatocellular carcinoma. Cardiovasc Intervent Radiol 30 3 (2007) 512-514
63. Chung J.W., Park J.H., Im J.G., Han J.K., and Han M.C. Pulmonary oil embolism after transcatheter oily chemoembolization of hepatocellular carcinoma. Radiology 187 (1993) 689-693
64. Lee J.K., Chung Y.H., Song B.C., et al. Recurrences of hepatocellular carcinoma following initial remission by transcatheter arterial chemoembolization. J Gastroenterol Hepatol 17 (2002) 52-58
65. Yoshikawa M., Ebara M., Fukuda H., Sugiura N., and Saisho H. Diagnosis and treatment for recurrent hepatocelluar carcinoma. Jpn J Cancer Chemother 25 (1998) 327-332
66. Chung Y.-H., Song I.H., Song B.C., et al. Combined therapy consisting of intraarterial cisplatin infusion and systemic interferon for hepatocellular carcinoma patients with major portal vein thrombosis or distant metastasis. Cancer 88 (2000) 1986-1991
67. Park S.H., Cho Y.K., Ahn Y.S., Park Y.O., Kim J.K., and Chung J.W. Local recurrence of hepatocellular carcinoma after segmental transarterial chemoembolization: risk estimates based on multiple prognostic factors. Korean J Radiol 8 2 (2007) 111-119
68. Ikeda M., Okada S., Yamamoto S., et al. Prognostic factors in patients with hepatocellular carcinoma treated by transcatheter arterial embolization. Jpn J Clin Oncol 32 11 (2002) 455-460
69. Savastano S., Miotto D., Casarrubea G., Teso S., Chiesura-Corona M., and Feltrin G.P. Transcatheter arterial chemoembolization for hepatocellular carcinoma in patients with Child's grade A or B cirrhosis: a multivariate analysis of prognostic factors. J Clin Gastroenterol 28 (1999) 334-340
70. Takayasu K., Arii S., Ikai I., et al. Liver Cancer Study Group of Japan. Prospective cohort study of transarterial chemoembolization for unresectable hepatocellular carcinoma in 8,510 patients. Gastroenterology 131 2 (2006) 461-469
71. Testa R., Testa E., Giannini E., et al. Transcatheter arterial chemoembolisation for hepatocellular carcinoma in patients with viral cirrhosis: role of combined staging systems, Cancer Liver Italian Program (CLIP) and Model for End-stage Liver Disease (MELD), in predicting outcome after treatment. Aliment Pharmacol Ther 17 (2003) 1563-1569
72. Llovet J.M., Real M.I., Montana X., et al. Arterial embolisation or chemoembolisation versus symptomatic treatment in patients with unresectable hepatocellular carcinoma: a randomised controlled trial. Lancet 359 (2002) 1734-1739
73. Lo C.M., Ngan H., Tso W.K., et al. Randomized controlled trial of transarterial lipiodol chemoembolization for unresectable hepatocellular carcinoma. Hepatology 35 (2002) 1164-1171
74. Huang Y.H., Wu J.C., Chen S.C., et al. Survival benefit of Transcatheter arterial chemoembolization in patients with hepatocellular carcinoma larger than 10 cm in diameter. Aliment Pharmacol Ther 23 1 (2006) 129-135
75. Ernst O., Sergent G., Mizrahi D., Delemazure O., Paris J.C., and L'Herminé C. Treatment of hepatocellular carcinoma by transcatheter arterial chemoembolization: comparison of planned periodic chemoembolization and chemoembolization based on tumor response. AJR Am J Roentgenol 172 1 (1999) 59-64
76. Lee H.S., Kim J.S., Choi I.J., Chung J.W., Park J.H., and Kim C.Y. The safety and efficacy of transcatheter arterial chemoembolization in the treatment of patients with hepatocellular carcinoma and main portal vein obstruction. A prospective controlled study. Cancer 79 11 (1997) 2087-2094
77. Pelletier G., Roche A., Ink O., et al. A ramdomized trial of hepatic arterial chemoembolization in patients with unresectable hepatocellular carcinoma. J Hepatol 11 (1990) 181-184
78. Groupe d'Etude et de Traitement du Carcinome Hepatocellulaire. A comparison of lipiodol chemoembolization and conservative treatment for unresectable hepatocellular carcinoma. N Engl J Med 332 (1995) 1256-1261
79. Tanaka K., Nakamura S., Numata K., et al. The long-term efficacy of combined transcatheter arterial embolization and percutaneous ethanol injection in the treatment of patients with large hepatocellular carcinoma and cirrhosis. Cancer 82 1 (1998) 78-85
80. Foxton M.R., Portmann B., Muiesan P., et al. Survival after liver transplantation for hepatocellular carcinoma based on Milan, UCSF and extended criteria. Hepatology 40 S1 (2004) 547A
81. De Carlis L., Giacomoni A., Lauterio A., et al. Liver transplantation for hepatocellular cancer: should the current indication criteria be changed?. Transpl Int 16 (2003) 115-122
82. Margarit C., Charco R., Hidalgo E., Allende H., Castells L., and Bilbao I. Liver transplantation for malignant diseases: selection and pattern of recurrence. World J Surg 26 2 (2002) 257-263
83. Figueras J., Ibañez L., Ramos E., et al. Selection criteria for liver transplantation in early-stage hepatocellular carcinoma with cirrhosis: results of a multicenter study. Liver Transpl 7 10 (2001) 877-883
84. Pelletier G., Ducreux M., Gay F., et al. Treatment of unresectable hepatocellular carcinoma with lipiodol chemoembolization: a multicenter randomized trial. Groupe CHC. J Hepatol 29 1 (1998) 129-134
85. Bruix J., Llovet J.M., Castells A., et al. Transarterial embolization versus symptomatic treatment in patients with advanced hepatocellular carcinoma: results of a randomized, controlled trial in a single institution. Hepatology 27 (1998) 1578-1583
86. Venook A.P., Ferrell L.D., Roberts J.P., et al. Liver transplantation for hepatocellular carcinoma: results with preoperative chemoembolization. Liver Transpl Surg 1 (1995) 242-248
87. Perez Saborido B., Meneu J.C., Moreno E., Garcia I., Moreno A., and Fundora Y. Is transarterial chemoembolization necessary before liver transplantation for hepatocellular carcinoma?. Am J Surg 190 (2005) 383-387
88. Oldhafer K.J., Chavan A., Fruhauf N.R., et al. Arterial chemoembolization before liver transplantation in patients with hepatocellular carcinoma: marked tumor necrosis, but no survival benefit?. J Hepatol 29 (1998) 953-959
89. Cancer of the Liver Italian Program (CLIP) Investigators. A new prognostic system for hepatocellular carcinoma: a retrospective study of 435 patients. Hepatology 28 3 (1998) 751-755